Combined interferon-α and interleukin 2 as adjuvant treatment for melanoma

被引：19

作者：

Dummer, R

Hauschild, A

Henseler, T

Burg, G

机构：

[1] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany

[2] Univ Clin Zurich, Dept Dermatol, Zurich, Switzerland

来源：

LANCET | 1998年 / 352卷 / 9131期

关键词：

D O I：

10.1016/S0140-6736(05)60052-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：908 / 909

页数：2

共 5 条

[1] Adjuvant immunotherapy in malignant melanoma: Impact of antibody formation against interferon-alpha on immunoparameters in vivo [J].

DavisDaneshfar, A ;

Boni, R ;

vonWussow, P ;

Joller, H ;

Burg, G ;

Dummer, R .

JOURNAL OF IMMUNOTHERAPY, 1997, 20 (03) :208-213

[2]

Dummer R., 1995, Melanoma Research, V5, P445, DOI 10.1097/00008390-199512000-00019

[3] Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1•5 mm without clinically detectable node metastases [J].

Grob, JJ ;

Dreno, B ;

de la Salmonière, P ;

Delaunay, M ;

Cupissol, D ;

Guillot, B ;

Souteyrand, P ;

Sassolas, B ;

Cesarini, JP ;

Lionnet, S ;

Lok, C ;

Chastang, C ;

Bonerandi, JJ .

LANCET, 1998, 351 (9120) :1905-1910

[4] Adjuvant IFNα2 therapy of melanoma [J].

Kirkwood, JM .

LANCET, 1998, 351 (9120) :1901-1903

[5] INFLUENCE OF VARIOUS CYTOKINES ON THE INTERLEUKIN-2-DEPENDENT LYSIS OF MELANOMA-CELLS IN-VITRO [J].

SCHULTZ, ES ;

DUMMER, R ;

BECKER, JC ;

ZILLIKENS, D ;

BURG, G .

ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 286 (02) :73-76

← 1 →